1.       Djarmati A, Dobričić V, Kecmanović M, Marsh P, Jančić-Stefanović J, Klein C, Djurić M, Romac S. MECP2 mutations in Serbian Rett syndrome patients. Acta Neurol Scand 2007; 116(6): 413-9 M22 IF 2,099

2.       Ostojić J, Jančić J, Kozić D, Semnic R, Koprivšek K, Prvulović M, Kostić V. Brain white matter 1 H MRS in Leber optic neuropathy mutation carriers. Acta Neurol Belg 2009; 109(4): 305-9 M23 IF 0,597

3.       Marinković S, Ćetković M, Gibo H, Todorović V, Jančić J, Milisavljević M. Immunohistochemistry of Displaced Sensory Neurons in the Trigeminal Nerve Root. Cells Tissues Organs 2010; 191(4): 326-35 M21 IF 2,302

4.       Stevanovic D, Jancic J, Lakic A. The impact of depression and anxiety disorder symptoms on the health-related quality of life of children and adolescents with epilepsy. Epilepsia 2011; 52(8): 75-8 M21 IF 3,961

5.       Damnjanović M, Lakić A, Stevanović D, Jovanović A, Jančić J, Jovanović M, Leposavić L. Self-assessment of the quality of life of children and adolescents in the child welfare system of Serbia. Vojnosanit Pregl 2012; 69(6): 469-74 M23 IF 0,210

6.       Stevanovic D, Jancic J, Topalovic M, Tadic I. Agreement between children and parents when reporting anxiety and depressive symptoms in pediatric epilepsy. Epilepsy Behav 2012; 25(2): 141-4 M22 IF 1,844

7.       Samardžić J, Savić K, Stefanović N, Matunović R, Baltezarević D, Obradović M, Jančić J, Oprić D, Obradović D. Anxiolytic and antidepressant effect of zinc on rats and its impact on general behavioural parameters. Vojnosanit Pregl 2013; 70(4): 391-5 M23 IF 0,269

8.       Samardžić J, Jadžić D, Radovanović M, Jančić J, Obradović D, Gojković-Bukarica LJ, Šćepanović R. The effects of resveratrol on rat behaviour in the forced swim test. Srp Arh Celok Lek 2013; 141(9-10): 582-5 M23 IF 0,169

9.       Babović R, Milićević S, Radovanović S, Jančić J. Testing of urodynamic dysfunctions in patients with multiple sclerosis. Vojnosanit Pregl. 2014; 71(5): 446-50 M23 IF 0,292

10.    Jančić J, Dejanović I, Samardžić J, Radovanović S, Pepić A, Kosanović-Jaković N, Ćetković M, Kostić V. Leber hereditary optic neuropathy in the population of Serbia. Eur J Paediatr Neurol 2014; 18(3): 354-9 M21 IF 2,301

11.    Petrusic I, Pavlovski V, Vucinic D, Jancic J. Features of migraine aura in teenagers. J Headache Pain 2014; 15:87: 1-6 M22 IF 2,801

12.    Jancic J, Petrusic I, Pavlovski V, Savkovic Z, Vucinic D, Martinovic Z. Pattern-Reversal Visual Evoked Potential Parameters and Migraine in the Teenage Population. J Child Neurol 2016; 31(6): 717-21. M23 IF 1,378

13.    Jancic J, Dejanovic I, Radovanovic S, Ostojic J, Kozic D, Duric-Jovicic M, Samardzic J, Cetkovic M, Kostic V. White Matter Changes in Two Leber’s Hereditary Optic Neuropathy Pedigrees: 12-Year Follow-Up. Ophthalmologica 2016; 235(1): 49-56. M22 IF 1,742

14.    Jancic J, Duric V, Ivancevic N, Nikolic B, van den Anker JN, Samardzic J. Current use of mTOR inhibitors for the treatment of subependymal giant cell astrocytomas and epilepsy in patients with TSC. Curr Med Chem 2016; 23(37): 4260-9. M21 IF 3,249

15.    Dujmovic I, Jancic J, Dobricic V, Jankovic M, Novakovic I, Comabella M, Drulovic J. Are Leber’s mitochondial DNA mutations associated with aquaporin-4 autoimmunity? Mult Scler 2016; 22: 393-4. M21 IF 4,840

16.    Ostojic S, Stevanovic D, Jancic J. Quality of life and its correlates in adolescent multiple sclerosis patients. Mult Scler Relat Disord 2016; 10: 57-62. M22 IF-2,349

17.    Stevanovic D, Lalic B, Batinic J, Damjanovic R, Jovic V, Brkic-Cvetkovic S, Jancic J. Childrens negative cognitive error questionnaire – Revised: The factor structure and association with anxiety and depressive symptoms across age, gender, and clinical/community samples. Cogn Ther Res 2016; 40(4): 584-92. M22 IF 2,313

18.    Petrusic I, Pavlovski V, Savkovic Z, Vucinic D, Filipovic B, Jancic J. Addenbrooke’s cognitive examination test for brief cognitive assessment of adolescents suffering from migraine with aura. Acta Neurol Belg 2017; 117(1): 97-102. M23 IF 2,072

19.    Jancic J, Petrusic I, Pavlovski V, Savkovic Z, Vucinic D, Martinovic Z. Authors’ Response to the Comments on „Pattern-Reversal Visual Evoked Potential Parameters and Migraine in the Teenage Population“. J Child Neurol 2017; 32(3): 346. M23 IF 1,378

20.    Samardžić J, Borovčanin M, Đukić-Dejanović S, Jančić J, Đurić M, Obradović DI. In vivo methodology in behavioural pharmacology – where are we now? Vojnosanit Pregl 2017; 74(4): 354-60. M23 IF 0,405

21.    Jancic J, Samardzic J, Stojanovic S, Stojanovic A, Milanovic AM, Nikolic B, Ivancevic N, KosticV. Leber’s Hereditary Optic Neuropathy: Novel Views and Persisting Challenges. CNS Neurol Disord Drug Targets 2017; 16(8): 927-35. M23 IF 2,084

22.    Samardzic J, Hencic B, Jancic J, Jadzic D, Djuric M, Obradovic DI, Svob Strac D. Neurosteroid dehydroepiandrosterone improves active avoidance retrieval and induces antidepressant-like behavior in rats. Neurosci Lett 2017; 660: 17-21. M23 IF 2,159

23.    Kovacevic G, Stevanovic D, Bogicevic D, Nikolic D, Ostojic S, Tadic BV, Nikolic B, Bosiocic I, Ivancevic N, Jovanovic K, Samardzic J, Jancic J. A 6-month follow-up of disability, quality of life, and depressive and anxiety symptoms in pediatric migraine with magnesium prophylaxis. Magnes Res 2017; 30(4): 133-41. M23 IF 1,281

24.    Jančić J, Ivančević N, Nikolić B, Popović M, Martinović Ž, Stevanović D, Grbić M, Đurić V, Samardžić J. Visual evoked potentials – current concepts and future perspectives. Vojnosanit Pregl 2018; 75(5): 496–503. M23 IF 0,405

25.    Jancic J, Djuric V, Hencic B, van den Anker JN, Samardzic J. Comorbidity of Migraine and Epilepsy in Pediatrics: A Review. J Child Neurol 2018; 33(12): 801-8. M22 IF 2,092

26.    Chitnis T, Arnold DL, Banwell B, Brück W, Ghezzi A, Giovannoni G, Greenberg B, Krupp L, Rostásy K, Tardieu M, Waubant E, Wolinsky JS, Bar-Or A, Stites T, Chen Y, Putzki N, Merschhemke M, Gärtner J, PARADIGMS Study Group (Jancic J). Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis. N Engl J Med 2018; 379(11): 1017-1027.  M21a IF-70,670

27.    Stevanovic D, Bozic-Antic I, Stanojlovic O, Vojnovic Milutinovic D, Bjekic-Macut J, Jancic J, Macut D. Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): a psychometric study with the Serbian version. Women Health 2019; Mar 14: 1-11. M22 IF 1,162

28.    Ivancevic N, Novicic M, Miler-Jerkovic V, Jankovic M, Stevanovic D, Nikolic B, Popovic M, Jancic J. Does handedness matter? Writing and tracing kinematic analysis in healthy adults.Psihologija 2019; 52(4): 413-35. M23 IF 0,333

29.    Jancic J, Rovcanin B, Djuric V, Pepic A, Samardzic J, Nikolic B, Novakovic I, Kostic V. Analysis of secondary mtDNA mutations in families with Lebers hereditary optic neuropathy: Four novel variants and their association with clinical presentation. Mitochondrion 2020; 50: 132-8. M21 IF 3,992

30.    Ivancevic N, Miler-Jerkovic V, Stevanovic D, Jancic J, Popovic M. Writing kinematics and graphic rules in children with ADHD. Srp Arh Celok Lek 2020; 148(7-8): 462-8. M23 IF 0,142

31.    Dawod PGA, Jancic J, Marjanovic A, Brankovic M, Jankovic M, Samardzic J, Potkonjak D, Djuric V, Mesaros S, Novakovic I, Abdel Motaleb FI, Kostic VS, Nikolic D. Whole Mitochondrial Genome Analysis in Serbian Cases of Leber’s Hereditary Optic Neuropathy. Genes 2020; 11(9):1037. M21 IF 3,759

32.    Rovcanin B1, Jancic J1, Samardzic J, Rovcanin M, Nikolic B, Ivancevic N, Novakovic I, Kostic V (1 Contributed equally). In silico model of mtDNA mutations effect on secondary and 3D structure of mitochondrial rRNA and tRNA in Leber’s hereditary optic neuropathy. Exp Eye Res 2020; 201:108277. M21 IF 3,011

33.    Rovcanin B1, Jancic J1, Pajic J, Rovcanin M, Samardzic J, Djuric V, Nikolic B, Ivancevic N, Novakovic I, Kostic V (1 Contributed equally). Oxidative Stress Profile in Genetically Confirmed Cases of Leber’s Hereditary Optic Neuropathy. J Mol Neurosci 2020; Oct 23. doi: 10.1007/s12031-020-01729-y. M22 IF 2,678

34.    Peric S., Stevanovic J., Johnson K., Kosac A. et al. Phenotypic and genetic spectrum of patients with limb-girdle muscular dystrophy type 2A from Serbia. Acta Myol. 2019 Sep; 38(3): 163–171.

35.    Kosac A, Jović N. Tuberous sclerosis complex, Serbian referral center experience. Vojnosanit Pregl. 2019; 76 (8): 817-821.

36.    Lanza G, Kosac A, Trajkovic G, Whittaker RG. Nerve Conduction Studies as a Measure of Disease Progression: Objectivity or Illusion? J Neuromuscul Dis. 2017;4(3):209-215.

37.    Brkušanin M, Kosać A, Jovanović V, Pešović J, Brajušković G, Dimitrijević N, Todorović S, Romac S, Milić Rašić V, Savić-Pavićević D. Joint effect of the SMN2 and SERF1A genes on childhood-onset types of spinal muscular atrophy in Serbian patients. J Hum Genet. 2015 Nov;60(11):723-8.

38.    Jovic N, Kosac A, Babić MD. Terminal remission is possible in some patients with juvenile myoclonic epilepsy without therapy. Med Pregl. 2014 Nov-Dec;67(11-12):372-8.

39.    Jovic N, Kosac A, Koprivsek K. L-2-Hydroxyglutaric aciduria: a case report. Srp Arh Celok Lek. 2014 May-Jun;142(5-6):337-41.

40.    Bladen CL, Thompson R, Jackson JM, Garland C, Wegel C, Ambrosini A, Pisano P, Walter MC, Schreiber O, Lusakowska A, Jedrzejowska M, Kostera-Pruszczyk A, van der Pol L, Wadman RI, Gredal O, Karaduman A, Topaloglu H, Yilmaz O, Matyushenko V, Rasic VM, Kosac A, et al. Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe. J Neurol. 2014;261(1):152-63.

41.    MilicRasic V, Vojinovic D, Pesovic J, Mijalkovic G, Lukic V, Mladenovic J, Kosac A, Novakovic I, Maksimovic N, Romac S, Todorovic S, Savic Pavicevic D. Intellectual ability in Duchenne muscular dystrophy and dystrophin gene mutation location. Balk J Med Gen 2014;17:25-36. 

42.    Kosac A, Gavillet E and Whittaker RG. Neurophysiological testing in congenital myasthenic syndromes: A systematic review of published normal data. Muscle Nerve. 2013;48(5):711-5.

43.    Stevanović D. Introduction to the Special Issue on problematic behaviors related to Internet and digital technology use: Facts, conjectures, and oranges. Psihologija. 2020;53(3):225-36.

44.    Stevanović D, Đorić A, Balhar Pal SB, Ćirović N, Arya S, Ransing R, Vu TT, Ngoc HT, Tadić I, Jović J, Radovanović S. Assessing the symptoms of Internet Gaming Disorder among college/university students: An international validation study of a self-report. Psihologija. 2020;53(1):43-63.

45.    Doric A, Stevanovic D, Stupar D, Vostanis P, Atilola O, Moreira P, et al. UCLA PTSD reaction index for DSM-5 (PTSD-RI-5): a psychometric study of adolescents sampled from communities in eleven countries. European journal of psychotraumatology. 2019 Jan 1;10(1):1605282.

46.    Stevanovic D, Bozic-Antic I, Stanojlovic O, Vojnovic Milutinovic D, Bjekic-Macut J, Jancic J, Macut D. Health-related quality of life questionnaire for polycystic ovary syndrome (PCOSQ-50): a psychometric study with the Serbian version. Women & health. 2019, 15:1-1.

47.    Stevanovic D, Zalsman G. Changes in cognitive distortions and affectivity levels in adolescent depression after acute phase fluoxetine treatment. Cognitive neuropsychiatry. 2019;24(1):4-13.

48.    Stevanovic D, Knez R, Zorcec T, Anderluh M, Kodrič J, et al. ESSENCE-Q: Slavic language versions for developmental screening in young children. Neuropsychiatric disease and treatment. 2018;14:2141.

49.    Stevanovic D, Brajkovic L, Srivastava MK, Krgovic I, Jancic J. Widespread cortical PET abnormalities in an adolescent related to a PNES dissociative state, PTSD, ADHD, and domestic violence exposure. Scandinavian Journal of Child and Adolescent Psychiatry and Psychology. 2018;6(2):98-106.

50.    Stevanovic D, Jafari P, Knez R, Franic T, Atilola O, et al. Can we really use available scales for child and adolescent psychopathology across cultures? A systematic review of cross-cultural measurement invariance data. Transcultural Psychiatry. 2017 Feb;54(1):125-52.

51.    Stevanovic D, Bagheri Z, Atilola A, Vostanis P, Stupar D, et al. Cross-cultural measurement invariance of the Revised Child Anxiety and Depression Scale across 11 world-wide societies. Epidemiology and Psychiatric Sciences. 2017;26(4):430-440.

52.    Stevanovic D, Lalic B, Batinic J, Damjanovic R, Jovic V. Metacognitions questionnaire for children: development and validation of the Serbian version. Journal of Evidence-Based Psychotherapies, 2016, 16: 135-151.

53.    Stevanovic D, Lalic B, Batinic J, Damjanovic R, Jovic V, et al. Children’s Negative Cognitive Error Questionnaire—Revised: The Factor Structure and Associations with Anxiety and Depressive Symptoms Across Age, Gender, and Clinical/Community Samples. Cognitive Therapy and Research, 2016, 40:584–592.

54.    Jafari P, Bagheri Z, Stevanovic D. Cross-cultural Measurement Equivalence of the KINDL Questionnaire for Quality of Life Assessment in Children and Adolescents. Child Psychiatry & Human Development, 2016, 47(2), 291-304.

55.    Stevanovic D, Maroco J, Atilola O, Vostanis P, Pal Singh Balhara Y, et al. Can we compare quality of life among adolescents across the globe? Testing the measurement invariance of the PedsQLTM 4.0 across different countries. Journal of Research on Adolescence; 2016; 26(4): 687–695

56.    Paulo Moreira, João Machado Vaz,Dejan Stevanovic,Olayinka Atilola,Katarina Dodig-Ćurković,Tomislav Franic,Ana Djoric,Nikolina Davidovic,Mohamad Avicenna,Isa Multazam Noor,Monteiro Luis Antonio Campos,Adriana Ribas,Dusko Stupar,Azra Deljkovic et al. Locus of control, negative live events and psychopathological symptoms in collectivist adolescents. Personality and Individual Differences 2020, 154 109601 doi.org/10.1016/j.paid.2019.109601 M 22

57.    Doric, A., Stevanovic, D., Stupar, D., Vostanis, P., Atilola, O., Moreira, P., … & Noor, M. (2019). UCLA PTSD reaction index for DSM-5 (PTSD-RI-5): a psychometric study of adolescents sampled from communities in eleven countries. European Journal of Psychotraumatology10(1), 1605282. M21

58.    Pejovic-Milovancevic M, Kesic A, Grujicic R, Stojkovic A, Zivotic S, Stupar D, Borovnica V, Radosavljev-Kircanski J, Manojlovic I, Stojiljkovic DJ. Inpatient care in Serbia: trends in hospitalization and diagnostics over time. European child & adolescent psychiatry. 2018 Dec 1;27(12):1645-51. M21

59.    Božić B, Stupar S, Stupar D, Babić U, Bajčetić M. Availability of pediatric-evaluated formulations in Serbia. Indian journal of pharmacology. 2017 Mar;49(2):189. M23

60.    Milovancevic MP, Ispanovic V, Stupar D. Lessons learned from the past on mental health care of refugee children in Serbia. European child & adolescent psychiatry. 2016 Jun 1;25(6):669-72. M21

61.    Stupar, D., Lakić, A., Jančić, J., Antin-Pavlović, T., Marković, J., Joksimović, M., … & Srećković, N. (2015). Early screening for autism spectrum disorder in Serbia: A pilot study of screening instruments for parents and child care workers. Engrami37(4), 41-49. M52

62.    Dawod PGA, Jancic J, Marjanovic A, Brankovic M, Jankovic M, Samardzic J, Potkonjak D, Djuric V, Mesaros S, Novakovic I, Abdel Motaleb FI, Kostic VS, Nikolic D. Whole Mitochondrial Genome Analysis in Serbian Cases of Leber’s Hereditary Optic Neuropathy. Genes (Basel). 2020; 11(9):1037. M21, IF:3,759

63.    Vukićević D, Rovčanin B, Gopčević K, Stanković S, Vučević D, Jorgačević B, Mladenović D, Vesković M, Samardžić J, Ješić R, Radosavljević T. The role of MIF in hepatic function, oxidative stress, and inflammation in thioacetamide-induced liver injury in mice: Protective effects of betaine. Curr Med Chem 2020. Online ahead of print. M21, IF:3,894

64.    Jorgačević  B, Vučević  D, Samardžić  J, Mladenović  D, Vesković  M, Vukićević  D,  Ješić  R, Radosavljević T. The Effect  of CB1 Antagonism On Hepatic Oxidative/Nitrosative Stress And Inflammation In Nonalcoholic Fatty Liver Disease. Curr Med Chem 2020. Online ahead of print. M21, IF:3,894

65.    Vučević  D, Borozan S, Radenković A, Radosavljević M, Mladenović D, Jorgačević  B, Samardžić  J, Vesković  M, Vukićević  D,  Radosavljević T. Galectin-3 Deficiency Reduces Cardiac and Renal Antioxidant Capacity in Mice. Folia Biol Kraków 2020; 68(2):73-80. M23, IF:0,724

66.    Prodanovic S, Radunovic G, Babic D, Ristic B, Sefik-Bukilica M, Zlatanovic M, Simic-Pasalic K, Seric S, Vujasinovic-Stupar N, Samardzic J, Damjanov N. Matrix Metalloproteinases-3 Baseline Serum Levels in Early Rheumatoid Arthritis Patients Without Initial Radiographic Changes: A Two Year Ultrasonographic Study. Med Princ Pract. 2018; 27(4):378-386. M23, IF: 1,103

67.    Jovanovic B,  Djuric O,   Markovic-Denic Lj,  Isakovic A,  Doklestic K,  Stankovic S,  Vidicevic S,  Palibrk I,Samardzic J,  Bumbasirevic V. Prognostic value of presepsin (soluble CD14-subtype) in diagnosis of ventilator-associated pneumonia and sepsis in trauma patients. Vojnosanit Pregl. 2018; 75(10): 968–977. M23, IF:0,272

68.    Samardzic J, Hencic B, Jancic J, Jadzic D, Djuric M, Obradovic DI, Svob Strac D. Neurosteroid dehydroepiandrosterone improves active avoidance retrieval and induces antidepressant-like behavior in rats. Neurosci Lett. 2017;660:17-21. M23, IF:2,159

69.    Samardžić J, Borovčanin M, Đukić-Dejanović S, Jančić J, Đurić M, Obradović DI. In vivomethodology in behavioural pharmacology – where are we now? Vojnosanit Pregl. 2017; 74(4):354-360. M23, IF:0,405

70.    Samardzic J, Smits A, Spriet I, Soldatovic I, Atkinson A, Bajcetic M, Van Den Anker JN,Allegaert K. Different vancomycin immunoassays contribute to the variability in vancomycintrough measurements in neonates. Biomed Res Int. 2016;2016:1974972. M22, IF:2,476

71.    Wilbaux M, Fuchs A, Samardzic J, Rodieux F, Csajka C, Allegaert K, Den Anker JN, Pfister M. Pharmacometric approaches to personalize use of primarily renally eliminated antibiotics in preterm and term neonates. J Clin Pharmacol. 2016; 56(8):909-35. M22, IF:2,812

72.    Svob Strac D, Vlainic J, Samardzic J, Erhardt J, Krsnik Z. Effects of acute and chronic administration of neurosteroid dehydroepiandrosterone sulfate on neuronal excitability in mice. Drug Des Devel Ther. 2016; 10:1201-15. M22, IF:2,822

73.    Samardzic J, Allegaert K, Wilbaux M, Pfister M, van den Anker JN. Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period. Expert Opin Drug Metab Toxicol. 2016; 12(4):367-75. M22, IF:3,027

74.    Samardzic J, Allegaert K, Bajcetic M. Developmental pharmacology: a moving target. Int J Pharm. 2015; 492(1-2): 335-7. M21, IF:3,994

75.    Samardzic J, Turner MA, Bax R, Allegaert K. Neonatal Medicines Research:  challenges and opportunities. Expert Opin Drug Metab Toxicol. 2015; 11(7): 1041-52. M22, IF:2,598

76.    Ferrario A, Baltezarevic D, Novakovic T, Parker M, Samardzic J. Evidence-based decision making in healthcare in Central Eastern Europe. Expert Rev Pharmacoecon Outcomes Res 2014;14(5):611-615. M22, IF:1,669

77.    Samardzic J, Pukas L, Obradovic M, Lazic-Puskas D, Obradovic DI. Antidepressant effects of an inverse agonist selective for alpha 5 GABA-A receptors in the rat forced swim test. Acta Vet. 2014; 64 (1):52-60. M23, IF:0,375

78.    Samardzic J, Savic K, Stefanovic N, Matunovic R, Baltezarevic D, Obradovic M, Jancic J, Opric D, Obradovic DI. Axiolytic and antidepressant effect of zinc in rats and its impact on general behavioural parameters. Vojnosanit Pregl. 2013; 70(4):391–395. M23, IF: 0,269

79.    Samardzić J, Jadzić D, Radovanović M, Jancić J, Obradović DI, Gojković-Bukarica L, Sćepanović R. [The effects of resveratrol on rat behaviour in the forced swim test]. Srp Arh Celok Lek. 2013;141(9-10):582-5. M23, IF:0,169

80.    Samardzic J, Svob Strac D, Obradovic M, Opric D, Obradovic DI. DMCM, a benzodiazepine site inverse agonist, improves active avoidance and motivation in the rat. Behav Brain Res. 2012;235(2):195–199. M21, IF:3,327

81.    Matunović R, Samardžić J, Špirić Ž, Marinković D, Gudelj O, Obradović DI, Mijailović Z, Rafajlovski S. Pharmacological treatment of stress-induced hypertension – guidelines and dilemmas. Vojnosanit Pregl 2011; 68(12):1057–1062.M23, IF:0,179

82.    Savić MM, Clayton T, Furtmüller R,Gavrilović I, Samardžić J, Savić S, Huck S, Sieghart W, Cook JM. PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats. Brain Research 2008; 1208: 150-159. M22, IF:2,494

83.    Vukašinović Z, Čobeljić G, Vučetić Č, Spasovski D, Samardžić J. Radiological screening of DDH is not necessary at all! J Bone Joint Surg Br, 2006 (e letter – 9 November 2006). M21, IF:1,790

84.    Vukašinović Z, Vučetić Č, Čobeljić G, Spasovski D, Samardžić J. Is prophylactic contralateral pinning in unilateral slipped upper femoral epiphysis justified? J Bone Joint Surg Br, 2006 (e letter – 9 November 2006). M21, IF:1,790

85.    Simić S, Vukasinović Z, Samardžić J, Pejcić I, Lukavac-Tesin M, Spasovski D, Bozinović-Prekajski N. Does the gestation age of newborn babies influence the ultrasonic assessment of hip condition? Srp Arh Celok Lek. 2009;137(7-8):402-8.

86.    Samardžić J. Pharmacogenetics of antidepressants: A step to individualized therapy. Srpski medicinski časopis Lekarske komore 2020; 1(1):13-20.

87.    Latas M, Samardžić J, Perović S, Nešić Z, Milovanović S. An observational study comparing the efficacy of duloxetine and pregabalin in patients with generalized anxiety disorder. Engrami 2020; 42(1):20-31.

88.    Samardžić J, Zeković J, Stevanović A, Jančić J, Dimitrijević I. Benzodiazepine (ab)use and addictive potential: Analyses of consumption in Serbia for the period 2014-2016. Engrami 2018; 40(2):73-85.

89.    Vesic K, Djukic-Dejanovic S, Borovcanin M, Samardzic J, Toncev G. Cannabis as a possible treatment for spasticity in multiple sclerosis. Ser J Exp Clin Res 2016; 17 (1): 61-66.

90.    Samardžić J, Savić K, Baltezarević D, Matunović R, Obradović M, Jančić J, Obradović DI. Anxiolytic and antidepressive effects of magnesium in rats and their effect on general behavioural parameters. Veterinarski glasnik 2011; 65(5-6):323-332.

91.    Kostić V, Marinković Z, Filipović S and Momčilović D (1993): Function of Dopamine Receptors in Young – onset Parkinson’s Disease: Prolactin Response. Movement Disorder, 1993; 8 (2): 227-229.

92.    Kostić V., Filipović S., Lečić D., Momčilović D., Sokić D., Šternić N. (1994): Effect of Age at Onset on Frequency of Depression in Parkinson’s Disease. Journal of   Neurology, Neurosurgery and Psychiatry, 1994; 57:1265-1267        

93.    Stefanova E, Đarmati A, Momčilović D, Dragašević N, Svetel M, Klein C, Kostic VS (2006): Clinical characteristics of paroxysmal nonkinesigenic dyskinesia in serbian family with Myofibrillogenesis regulator 1 gene mutation. Mov Disord 2006; 21 (11) : 2010-2015.                                                                      

94.    Periša Simonović, Milutin Nenadović, Dragana Momčilović (2011): Reasons and Conditions for Involuntary Hospitalization with Special Emphasis on Detention without Consent of Mentally Disordered Person who Voluntarily Started Hospital Treatment. Srp Arh Celok Lek 2011;139 (supl 1) : 21-25. (Review Article).

95.    Ledoux MS, Xiao J, Rudzinska M, Bastian RW, Wszolek ZK,Van Gerpen JA, Puschmann A, Momčilović D, Vermula SR, Zhao Y (2012): Genotype-phenotype correlations in THAP1dystonia: Molecular foundations and description of new cases. Parkinsonism Relat Disord. 2012;18 (5):414-25. Epub 2012 Feb 28.

96.    Hedera P, Xiao J, Puschmann A, Momčilović D, Wu SW, Ledoux MS (2012): Novel PRRT2 mutation in an African-American family with paroxysmal kinesigenic dyskinesia. BMC Neurol. 2012 Sep 18; 12:93.

97.    Dragana Momčilović – Kostadinović,  Periša Simonović, Dušan Kolar, Nebojša Jović (2013): Epileptički status izazvan hlorpromazinom-prikaz bolesnika. Srp Arh Celok Lek. 2013; 141 (9-10):667-670.                                    

98.    Satya R Vemula , Xiao Jianfeng , Robert W Bastian R, Dragana  R.Momčilović,  Andrew Blitzer, Mark S. LeDoux: Pathogenic Variants in TUBB4A are not found in Primary Dystonia; Neurology 2014; 82 (14):1227-30.  Epub 2014 Mar 5.

99.    Vemula SR, Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Truong DD, Blitzer A, Rudzińska M, Momčilović D, Jinnah HA, Frei K, Pfeiffer RF, LeDoux MS.:“ A rare sequence variant in intron 1 of THAP1 is associated with primary dystonia“.Mol Genet Genomic Med. 2014, May;2(3):261-72. Epub 2014 Feb 11.

100.Dragana R. Momčilović-Kostadinović (2010): „Distonije detinnjstva i adolescentnog doba“. ISSN 1450-801X;246; ISBN 978-86-7244-877-1. Izdavač : „Zadužbina Andrejević“, Beograd, 2010

101.Stevanović Galina, Jović Nebojša, Kecmanović Miljana, Is adjunctive perampanel beneficial for Lafora disease?Vojnosanitetski pregled 2020; 77 (5):539-4

102.Kecmanović M, Keckarević-Marković M, Keckarević D, Stevanović G, Jović N, Romac S.Genetics of Lafora progressive myoclonic epilepsy: current perspectives. Appl Clin Genet. 2016 May 2;9:49-53.

103.Kecmanović M, Jović N, Keckarević-Marković M, Keckarević D, Stevanović G,  Ignjatović P, Romac S. Clinical and genetic data on Lafora disease patients of Serbian/Montenegrin origin. Clin Genet. 2016 Jan;89(1):104-8.

104.Kostić N, Dotsikas Y, Jović N, Stevanović G, Malenović A, Medenica M. Quantitation of pregabalin in dried blood spots and dried plasma spots by validated LC-MS/MS methods. J Pharm Biomed Anal. 2015 May 10;109:79-84.

105.Kecmanović M, Jović N, Cukić M, Keckarević-Marković M, Keckarević D, Stevanović G, Romac S. Lafora disease: severe phenotype associated with homozygous deletion of the NHLRC1 gene. J Neurol Sci 2013; 325 (1-2): 170-173.

106. Savic D, Topisirovic I, Keckarevic M, Keckarevic D, Major T, Culjkovic B, Stojkovic O,  Rakocevic-Stojanovic V, Mladenovic J, Todorovic S, Apostolski S, Romac S. Is the 31 CAG repeat allele of the spinocerebellar ataxia 1 (SCA1) gene locus non-specifically associated with trinucleotide expansion diseases? Psychiatr Genet. 2001;11(4):201-5. M23, IF 1.257.

107.Savic D, Rakocevic-Stojanovic V, Keckarevic D, Culjkovic B, Stojkovic O, Mladenovic J, Todorovic S, Apostolski S, Romac S. 250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1. Hum Mutat. 2002; 19(2):131-9.  M21, IF 6.894.

108.Krndija D, Savic D, Mladenovic J, Rakocevic-Stojanovic V, Apostolski S, Todorovic S, Romac S. Haplotype analysis of the DM1 locus in the Serbian population. Acta Neurol Scand. 2005;111(4):274-7. M22, IF 1.982.

109.Mladenovic J, Pekmezovic T, Todorovic S, Rakocevic-Stojanovic V, Savic D, Romac S, Apostolski S. Survival and mortality of myotonic dystrophy type 1(Steinert  disease) in the population of Belgrade. Eur J Neurol 2006;13(5):451-4. M22, IF 2.437.

110.Mladenovic J, Pekmezovic T, Todorovic S, Rakocevic-Stojanovic V, Savic D, Romac S,   Apostolski S. Epidemiology of myotonic dystrophy type 1 (Steinert disease) in Belgrade (Serbia). Clin Neurol Neurosurg. 2006;108(8):757-60. M23, IF 1.506.

111.Keckarevic-Markovic M, Milic Rasis V, Mladenovic J, Dackovic J, Kecmanovic M, Keckarevic D, Savic-Pavicevic D, Romac . Mutational analysis of GJB1, MPZ, PMP22, EGR2 aand LITAF/SIMPLE in Serbian Charcot-Marie-Tooth patients.  J Peripher Nerv Syst. 2009;14(2):125-36. M21, IF 3.371.

112.Potic A, Roveli AM, Uziel G, Kozic D, Mladenovic J, Milic-Rasic V. Childhood cerebral X- linked adrenoleukodystrophy more than 5 years after hematopoietic cell transplantation: the first case from Serbia and southeastern Europe. J Child Neurol. 2010;25(12):1542-7.  M23, IF 1.809.

113.Mladenovic J, Milic Rasic V, Keckarevic Markovic M, Romac S, Todorovic S, Rakocevic Stojanovic V, Kisic Tepavcevic D, Hofman A, Pekmezovic T. Epidemiology of Charcot-Maie-Tooth disease in the population of Belgrade, Serbia. Neuroepidemiology. 2011;36(3):177-82. M22, IF 2.817.

114.Keckarevic Markovic MP, Dackovic J, Mladenovic J, Milic-Rasic V, Kecmanovic M, Keckarevic D, Romac S. An algorithm for genetic testing of Serbian patients with demyelinating Charcot-Marie-Tooth. Genet Test Mol Biomarkers. 2013;17(1):85-7.  M23, IF 1.444.

115.Mladenović J, Pekmezović T, Todorović S, Rakocević-Stojanović V, Romac S, Apostolski S: Epidemiologija miotonične distrofije tip 1 u populaciji centralne Srbije. Vojnosanit Pregl. 2005;62(5):377-82.

116.D.Vučinić,  A.Kesić, J.Jančić, N.Jović.  Olfactory functioning in children with Attention deficit hyperactivity disorder. Engrami. Časopis za kliničku psihijatriju i granične discipline. Beograd. Vol 38; Jan-mart 2016, str 29-37.

117.A.Kesić, D.Vučinić. J.Marković, J.Jančić. Suicide attempts among children and adlescents. Engrami. Časopis za kliničku psihijatriju i granične discipline. Beograd. Jan-mart 2016 Vol 38, str 19-27.

118. D.Vucinic.Visual evoked potentials in children and adolescence with neurofibromatosis type 1.Clinical Neurophysiology 2015; 126(9):177 doi: 10.1016/j.clinph.2015.04.022

119. Sočanski VD, Jović JN, Vučinić MD. Behavioural disturbances in children with febrile convulsions.

Psychiatry Today 1997;29(1-2):123-137. Poremećaji ponašanja u dece sa febrilnim konvulzijama. Psihijatrija Danas, 1997; 29(1-2): 139-151.

120. Jović N, Nesović M, Vranješević D, Ćirić J, Marinković D, Bonači B. The Vogt-Koyanagi-Harada syndrome: association with autoimmune polyglandyular syndrome tip 1. Postgrad Med J, 1996; Vol 72 no 850 pp  495-7.

121. Jović N, Vranješević D, Jović J, Marinković D.:Sotosov sindrom (cerebralni gigantizam). Srp Arh Celok Lek1996; 124(1-2): 37-40.

122.Cerovac N, Petrovic I, Christine K, Kostic VS. Delayed-Onset Dystonia Due to Perinatal Asphyxia: A Prospective Study. Movement Disorders 2007< 22: 2426-2429.

123.Divac N, Prostran M, Jakocevski I, Cerovac N. Second-Generation Antypsychotics and Extrapiramidal Adverse Effects. BioMed Res Int 2014.

124.Ivancevic N, Cerovac N, Nikolic B, Cuturilo G, Marjanovic A, Brankovic M, Novakovic I. GLUT1 deficiency syndrome: a case report with a novel SLC2A1 mutation. Vojnosanitet Pregl 2019; 76(5):543-546.

125.Cerovac N, Terzic M, Borkovic M, Divac N, Stojanovic R, Prostran M. Prenatal diagnosis of lissencephaly: a case report. Vojnosanitet Pregl 2016; 73(1):77-82.

126.Medic B, Divac N, Stopic B, Savic Vujovic K, Glisic A, Cerovac N, Stojanovic R, Srebro D, Prostran M. The attitudes of medical students toward rare diseases: A cross-sectional study. Vojnosanitet Pregl 2016; 73(8):703-713.

127.Prostran M, Savic Vujovic K, Vuckovic S, Medic B, Srebro D, Divac N, Stojanovic R, Vujovic A, Jovanovic L, Jotic A, Cerovac N. Pharmacotherapy of Pain in the Older Population: The Place of Opoids.  Frontiers in Aging Neuroscience 2016; 8.

128.Glisic A, Divac N, Gojnic Dugalic M, Kastratovic Kotlica B, Vavic N, Cerovac N, Prostran M. The outcome of pregnancy in a kidney transplant patient: a case report and review of the literature. Vojnosanitet Pregl 2017; 74(8):778-781.

129. Nikolić B, Ivančević N, Zaletel I, Rovčanin B, Samardzˇić J, Jančić J (2020) Characteristics of pediatric multiple sclerosis: A tertiary referral center study. PLoS ONE 15(12): e0243031. https://doi.org/10.1371/journal.pone.0243031




Radovi iz 2021.god.

  1. B Nikolic, I Zaletel, N Ivancevic, B Rovcanin, A Pepic, J Samardzic, …J Jancic. The usefulness of visual evoked potentials in the assessment of the pediatric multiple sclerosis. European Journal of Paediatric Neurology 36 (2022) 130-136.
  2. R Waltereit, GB d’Augères, J Jancic, et al. Involvement of mental health professionals in the treatment of tuberous sclerosis complex–associated neuropsychiatric disorders (TAND): results of a multinational European electronic survey. Orphanet journal of rare diseases 16 (1), 1-14
  3. PGA Dawod, J Jancic, A Marjanovic, et al. Mutational Analysis and mtDNA Haplogroup Characterization in Three Serbian Cases of Mitochondrial Encephalomyopathies and Literature Review. Diagnostics 11 (11),1969                            
  4. Rovcanin B1, Jancic J1, Pajic J, Rovcanin M, Samardzic J, Djuric V, Nikolic B, Ivancevic N, Novakovic I, Kostic V (1 Contributed equally). Oxidative Stress Profile in Genetically Confirmed Cases of Leber’s Hereditary Optic Neuropathy. J Mol Neurosci 2021; 71(5): 1070- 81.
  5. N Nenezić, R Matunović, O Gudelj, I Đurić, J Jančić, J. Stress and arterial hypertension-from pathophysiology to pharmacology. Samardžić Srpski arhiv za celokupno lekarstvo, 66-66   
  6. J Milić, J Zeković, D Stankić, B Henčić, J Jančić, J Samardžić. Cognition-enhancing drugs and applications to aging Assessments, Treatments and Modeling in Aging and Neurological Disease, 367-378                 
  7. Ž Rogač, D Stevanović, et al. Cognitive profile, psychopathological symptoms, and quality of life in newly diagnosed pediatric epilepsy: A six-month, naturalistic follow-up study. Epilepsy Research, 106844      
  8. C Arango, JK Buitelaar, , … Stevanovic D… Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled trial. The Lancet Psychiatry     
  9. D Stevanovic, B Kabukcu Basay, O Basay, et al. COVID-19 pandemic-related aspects and predictors of emotional and behavioural symptoms in youth with pre-existing mental health conditions: results from Georgia, Lithuania, Romania, Serbia, and Turkey.  Nordic Journal of Psychiatry, 1-8                  
  10. D Stevanović Neurorazvojni poremećaji u Međunarodnoj klasifikaciji bolesti, 11 izdanje (MKB-11): Pregled. Engrami 43 (1), 50-69          
  11. D Stevanovic, F Costanzo, E Fucà, et al. Measurement invariance of the Childhood Autism Rating Scale (CARS) across six countries. Autism Research 14 (12), 2544-2554                          
  12. D Stupar, D Stevanovic, P Vostanis, et al. Posttraumatic stress disorder symptoms among trauma-exposed adolescents from low-and middle-income countries. Child and adolescent psychiatry and mental health 15 (26)          
  13. D Stevanović. Quantitative Checklist for Autism in Toddlers (Q-CHAT): A psychometric study with Serbian Toddlers. Research in Autism Spectrum Disorders 83, 101760              
  14. D Ougrin, BHC Wong, M Vaezinejad, PL Plener, T Mehdi, L Romaniuk, …D Stevanovic. Pandemic-related emergency psychiatric presentations for self-harm of children and adolescents in 10 countries (PREP-kids): a retrospective international cohort study. European child & adolescent psychiatry, 1-13.
  15. Atilola, D Stevanovic, P Moreira, …Stupar D et al. External locus-of-control partially mediates the association between cumulative trauma exposure and posttraumatic stress symptoms among adolescents from diverse background. Anxiety, Stress, & Coping, 1-19            
  16. S Raščanin, M Jovanović, D Stevanović, N Rančić. Questionnaire for evaluating information, knowledge, and attitudes on donation, storage and application of induced pluripotent stem cells. Genetika 53 (2), 813-823                                                    
  17. N Kerekes, K Bador, … V Jovic, …D Stevanovic.  Changes in Adolescents’ Psychosocial Functioning and Well-Being as a Consequence of Long-Term COVID-19 Restrictions. International Journal of Environmental Research and Public Health 18 (16), 8755  
  18. BHC Wong, E Chkonia, L Panteleeva, I Pinchuk, D Stevanovic et al. Transitioning to community-based mental healthcare: reform experiences of five countries. BJPsych International, 1-3          
  19. R Knez, D Stevanovic, S Nasic, A Doric, E Wentz. The Impact of Methylphenidate on QbTest Performance of Children with ADHD: A Retrospective Clinical Study. Neuropsychiatric Disease and Treatment 17, 19
  20. Mercuri E, Deconinck N, Mazzone ES, Nascimento A, Oskoui M, Saito K, Vuillerot C, Baranello G, Boespflug-Tanguy O, Goemans N, Kirschner J, Kostera-Pruszczyk A, Servais L, Gerber M, Gorni K, Khwaja O, Kletzl H, Scalco RS, Staunton H, Yeung WY, Martin C, Fontoura P, Day JW; SUNFISH Study Group. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial. Lancet Neurol. 2022 Jan;21(1):42-52. doi: 10.1016/S1474-4422(21)00367-7.
  21. Beijer D, Agnew T, Rack JGM, … V Milic Rasic.  Biallelic ADPRHL2 mutations in complex neuropathy affect ADP ribosylation and DNA damage response. J.Life Sci Alliance. 2021 Sep 3;4(11):e202101057.
  22. Djordjevic SA, Milic-Rasic V, Brankovic V, Kosac A. Glucose and lipid metabolism disorders in children and adolescents with spinal muscular atrophy types 2 and 3. Neuromuscul Disord. 2021 Apr;31(4):291-299.
  23. Djordjevic SA, Milic-Rasic V, Brankovic V, Kosac A. Cardiac findings in pediatric patients with spinal muscular atrophy types 2 and 3. Muscle Nerve. 2021 Jan;63(1):75-83.
  24. Pelletier F, Perrier S, Cayami FK, … Potic A, et al. Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C. J Clin Endocrinol Metab. 2021 Jan 23;106(2):e660-e674.
  25. Keller M, Brennenstuhl H, …, Stevanović G, Fung CW. Assessment of intellectual impairment, health-related quality of life, and behavioral phenotype in patients with neurotransmitter related disorders: Data from the iNTD registry. J Inherit Metab Dis. 2021 Nov;44(6):1489-1502.
  26. Imbrici P, Conte E, Blunck R, …Brankovic V, Zanni G. A Novel KCNA2 Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-Aminopyridine. Int J Mol Sci. 2021 Sep 14;22(18):9913.
  27. Nicita F, Ginevrino M, Travaglini …, Brankovic V, … Heterozygous KIF1A variants underlie a wide spectrum of neurodevelopmental and neurodegenerative disorders. J Med Genet. 2021 Jul;58(7):475-483.  
  28. Nuovo S, Brankovic V, Caputi C, et al. Novel unconventional variants expand the allelic spectrum of OPHN1 gene. Am J Med Genet A. 2021 May;185(5):1575-1581.
  29. Nuovo S, Micalizzi A, Romaniello R, …  Brankovic V … Refining the mutational spectrum and gene-phenotype correlates in pontocerebellar hypoplasia: results of a multicentric study. J Med Genet. 2021 Mar 5:jmedgenet-2020-107497. 
  30. D Aleksic, M Borkovic, J Krivacic, I Petrusic, V Milic Rasic. Frameshift Mutation in Polar Rich Domain (PRD) of PQBP1 Gene Associated with Asymmetric Cerebellar Hemispheres: A Case Report of Renpenning Syndrome. Iranian Journal of Pediatrics, 31; https://doi.org/10.5812/ijp.111431